Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19

NCT04435353 is registered in ClinicalTrials.gov with Astana Medical University as lead sponsor.

NCT NCT04435353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19
Lead sponsor
Astana Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
March 22, 2020
Completion date
February 1, 2021
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxemia, respiratory distress syndrome